Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer.
Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer. Clin Cancer Res. 1996 Dec; 2(12):1993-8.
View in:
PubMed
subject areas
Breast Neoplasms
Cyclin-Dependent Kinase Inhibitor p16
DNA Methylation
DNA Mutational Analysis
Exons
Female
Gene Dosage
Gene Expression Regulation, Neoplastic
Humans
In Situ Hybridization, Fluorescence
Loss of Heterozygosity
Polymorphism, Single-Stranded Conformational
Proteins
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger
Tumor Suppressor Protein p14ARF
authors with profiles
Olufunmilayo Olopade